Global Diabetic Retinopathy Market Research Report: Information by Type (Non-proliferative and Proliferative), Treatment (Anti-VEGF Drugs, Laser Photocoagulation, Vitreoretinal Surgery, Steroid Injection), by End User (Hospitals, Ambulatory Surgical Centers, Others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027
Future Drivers and Constraints Impacting the Diabetic Retinopathy Market
Complications such as retinal detachment, blindness, vitreous hemorrhage, and glaucoma associated with diabetic retinopathy can result to loss of vision. Availability of treatment in the market, growing awareness about diabetic retinopathy, and growing prevalence of diabetes are propelling the market over the review period. With the growing demand for diagnostic tests for early detection also drives the market for diabetic retinopathy. Moreover, increasing disposable income along with the fear of vision loss has resulted in the patients to avail the required treatment. Availability of advanced technology along with minimal pain reducing laser treatment is expected that the patients adopt surgical treatment. This is further estimated to impact the market positively over the review period.
On the flip side, lack of awareness about diagnosis and treatment along with inaccuracy in the diagnostic test among the geriatric population are factors inhibiting the market growth over the assessment period.
Diabetic Retinopathy Market Scenario
The global diabetic retinopathy market is predicted to expand at 11.9 % CAGR during the forecast period (2018-2025), asserts Market Research Future (MRFR). This can be attributed to the growing patient population over the years. Diabetic retinopathy is usually referred to eye diseases in diabetic patients. High blood sugar level causes the blood vessels in the retina to damage which results in leakage and swelling of the blood vessels, thus stopping blood to pass through. Some of the common symptoms of diabetic retinopathy involve blurred vision, vision loss, dark strings or spots floating in the vision, impaired color vision, and empty or dark areas in your vision.
Get FREE Sample PDF (including COVID19 Impact Analysis) of Market Report @ https://www.marketresearchfuture.com/sample_request/5792
Global Diabetic Retinopathy Market Segmentation
The global diabetic retinopathy market size has been segmented based on diagnosis, type, indication, treatment, end-user, and region.
By mode of type, the global market for diabetic retinopathy has been segmented into proliferative advanced diabetic retinopathy and non-proliferative diabetic retinopathy. Among these, the non-proliferative diabetic retinopathy dominates the market due to the presence of a large number of patient population. Non-proliferative diabetic retinopathy is also known as background retinopathy which is the most common diabetic eye condition is causing blindness among the adults.
By mode of diagnosis, the global market for diabetic retinopathy has been segmented into anti-VEGF therapy, laser treatment, and vitrectomy. The laser treatment has been sub-segmented into scattering laser treatment and focal laser treatment. Among these, the segment for anti-VEGF therapy has been estimated to dominate the market due to high applicability of drugs in early diagnosis, fast recovery, and better treatment.
By mode of end-user, the global market for diabetic retinopathy has been segmented into diagnostic centers, hospitals and clinics, research institutes, and others.
Regional Analysis
Geographically, the market for diabetic retinopathy spans across America, Europe, Asia Pacific, and the Middle East and Africa.
America holds the largest market share owing to the growing focus on early diagnosis and diagnostic imaging. The U.S. being the largest market in the North American region, is driven by growing number of diagnostic tests in clinics and hospitals and high count of diabetic patients. Emphasis on preventive care and presence of major market players are also likely to stimulate the market growth during the assessment period.
In Europe, the market for diabetic retinopathy is mainly driven by the availability of treatment options and growing patient population in this region. With the rising importance of early diagnosis and treatment and growing emphasis on diabetes management are also estimated to trigger the market growth in this region. Germany is the largest contributor in this region due to high investment in R&D on lifestyle diseases such as cardiovascular disease, diabetes, obesity, and others.
In Asia Pacific region, the growth of the market is stimulated due to prevalence of chronic diseases like diabetes and obesity. Also, the presence of a high count of the geriatric population has also contributed to the market growth over the assessment period.
Moreover, the Middle East and African region showcase a steady growth owing to the growing number of diagnostic services and rising demand for diabetes management. The United Arab Emirates and Saudi Arabia are the largest contributors responsible for the market growth in this region.
Industry News
A group of graduate students from California Institute of Technology has designed glowing contact lenses to treat diabetic retinopathy. The lenses can be worn while sleeping, emitting enough of glow for the retina to detect. These lenses help to preserve the cells and the patient’s eyesight.
Competitive Analysis
Some of the prominent players operating the global market for diabetic retinopathy are BCN Peptides (Spain), Ampio Pharmaceuticals (U.S.), Novartis AG (Germany), Kowa Group (Japan), Bayer (Germany), Alimera Sciences (U.S.), Glycadia Pharmaceuticals (U.S.), Genentech (U.S.), Sirnaomics (U.S.), Actavis Plc (U.K.), Regeneron Pharmaceuticals Inc. (U.S.), ThromboGenics (U.S.), and others.
You Can Access Full report : https://www.marketresearchfuture.com/reports/diabetic-retinopathy-market-5792
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
No comments:
Post a Comment